Overview

Drug-Drug Interaction Study of Rucaparib, Rosuvastatin and Oral Contraceptives

Status:
Completed

Trial end date:
2021-06-09

Target enrollment:

Participant gender:

Summary

This study will investigate the drug-drug interactions (DDIs) between rucaparib and oral rosuvastatin (Arm A), and between rucaparib and oral ethinylestradiol and levonorgestrel (Arm B), with rucaparib as a perpetrator.

Phase:

Phase 1

Details

Lead Sponsor:

Clovis Oncology, Inc.

Treatments:

Contraceptive Agents
Contraceptives, Oral
Ethinyl Estradiol
Levonorgestrel
Rosuvastatin Calcium
Rucaparib